Elsevier, a global information analytics business specialising in science and health, has introduced ClinicalPath as the new brand name for Via Oncology, the cancer care management and clinical decision support tool that won ‘Best Computerized Decision Support Solution’ in the 2019 MedTech Breakthrough Awards. ClinicalPath will be featured at booth 103 at the Oncology Clinical Pathways Congress in Boston, Massachusetts, October 11-13, 2019.
The rebrand of Via Oncology to ClinicalPath reflects Elsevier’s commitment to providing oncology care teams with a clearer path to clinical decision making, by combining advanced technology with evidence-based content. ClinicalPath will continue to deliver guidance to oncologists based on the latest published evidence and best practices of physicians, helping to standardise care; connect patients to clinical trials; prompt orders for appropriate biomarker and genetic tests; enable actionable insight into care patterns, and ultimately improve patient outcomes through personalised treatment pathways. ClinicalPath covers more than 97 percent of the most common cancer cases in medical and radiation oncology and is delivered at the point-of-care through integration with leading electronic health record (EHR) technologies.
Across medical and radiation oncology, ClinicalPath consistently exceeds an 80 percent on-pathway rate, with oncologists opting to pursue treatments within the ClinicalPath recommended care guidelines. ClinicalPath has also been shown to increase the rate of patient accrual to clinical trials by up to four times the national average at practices focused on clinical research.
Visitors to Elsevier’s booth at the Oncology Clinical Pathways Congress will be able to speak to experts to discuss how ClinicalPath can best support oncology care teams.Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction. Click here to read the original press release.